Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

1(33%)

Results Posted

50%(1 trials)

Phase Distribution

Ph not_applicable

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

N/ANon-phased studies

2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Detailed Status

Completed2

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

active_not_recruiting133%

completed267%

Recent Activity

1 active trials

Showing 3 of 3

active_not_recruiting

Discriminant Capacity and Thresholds of Salivary Cortisol in Chemiluminescence in the Diagnosis of Hypercorticisms

NCT03974789

completednot_applicable

Diagnosis of Respiratory Viruses in Children With Rhinoswab Junior

NCT05043623

completednot_applicable

Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus

NCT01251744

Clinical Trials (3)

Showing 3 of 3 trials

NCT03974789

Discriminant Capacity and Thresholds of Salivary Cortisol in Chemiluminescence in the Diagnosis of Hypercorticisms

Active Not Recruiting

NCT05043623Not Applicable

Diagnosis of Respiratory Viruses in Children With Rhinoswab Junior

Completed

NCT01251744Not Applicable

Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus

Completed

All 3 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 3